Mobilizing Patient and Public Involvement in the Development of Real-World Digital Technology Solutions: Tutorial.

digital mobility measures digital mobility outcomes patient engagement patient involvement public-private partnership real-world mobility research consortium

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
27 10 2023
Historique:
received: 21 11 2022
accepted: 31 08 2023
revised: 09 08 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

Although the value of patient and public involvement and engagement (PPIE) activities in the development of new interventions and tools is well known, little guidance exists on how to perform these activities in a meaningful way. This is particularly true within large research consortia that target multiple objectives, include multiple patient groups, and work across many countries. Without clear guidance, there is a risk that PPIE may not capture patient opinions and needs correctly, thereby reducing the usefulness and effectiveness of new tools. Mobilise-D is an example of a large research consortium that aims to develop new digital outcome measures for real-world walking in 4 patient cohorts. Mobility is an important indicator of physical health. As such, there is potential clinical value in being able to accurately measure a person's mobility in their daily life environment to help researchers and clinicians better track changes and patterns in a person's daily life and activities. To achieve this, there is a need to create new ways of measuring walking. Recent advancements in digital technology help researchers meet this need. However, before any new measure can be used, researchers, health care professionals, and regulators need to know that the digital method is accurate and both accepted by and produces meaningful outcomes for patients and clinicians. Therefore, this paper outlines how PPIE structures were developed in the Mobilise-D consortium, providing details about the steps taken to implement PPIE, the experiences PPIE contributors had within this process, the lessons learned from the experiences, and recommendations for others who may want to do similar work in the future. The work outlined in this paper provided the Mobilise-D consortium with a foundation from which future PPIE tasks can be created and managed with clearly defined collaboration between researchers and patient representatives across Europe. This paper provides guidance on the work required to set up PPIE structures within a large consortium to promote and support the creation of meaningful and efficient PPIE related to the development of digital mobility outcomes.

Identifiants

pubmed: 37889531
pii: v25i1e44206
doi: 10.2196/44206
pmc: PMC10638632
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e44206

Subventions

Organisme : Department of Health
ID : 301677
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

©Alison Keogh, Ríona Mc Ardle, Mara Gabriela Diaconu, Nadir Ammour, Valdo Arnera, Federica Balzani, Gavin Brittain, Ellen Buckley, Sara Buttery, Alma Cantu, Solange Corriol-Rohou, Laura Delgado-Ortiz, Jacques Duysens, Tom Forman-Hardy, Tova Gur-Arieh, Dominique Hamerlijnck, John Linnell, Letizia Leocani, Tom McQuillan, Isabel Neatrour, Ashley Polhemus, Werner Remmele, Isabel Saraiva, Kirsty Scott, Norman Sutton, Koen van den Brande, Beatrix Vereijken, Martin Wohlrab, Lynn Rochester, Mobilise-D consortium. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.10.2023.

Références

Health Commun. 2019 Oct;34(11):1320-1328
pubmed: 29889560
Res Involv Engagem. 2020 Oct 27;6:63
pubmed: 33133636
Int J Environ Res Public Health. 2019 Oct 02;16(19):
pubmed: 31581632
Digit Biomark. 2019 Aug 16;3(2):92-102
pubmed: 32095769
Gerontologist. 2010 Aug;50(4):443-50
pubmed: 20145017
Front Med (Lausanne). 2018 Oct 09;5:270
pubmed: 30356834
Int J Environ Res Public Health. 2021 Jul 20;18(14):
pubmed: 34300136
Res Involv Engagem. 2021 Oct 11;7(1):73
pubmed: 34635179
J R Soc Med. 2019 Nov;112(11):456-458
pubmed: 31347947
NPJ Digit Med. 2019;2(1):
pubmed: 30868107
Nat Rev Neurol. 2022 Aug;18(8):449-450
pubmed: 35768654
Res Involv Engagem. 2021 Oct 30;7(1):77
pubmed: 34717755
Front Med (Lausanne). 2018 Aug 17;5:230
pubmed: 30175100
Res Involv Engagem. 2022 Apr 19;8(1):15
pubmed: 35440013
Front Med (Lausanne). 2018 Nov 08;5:310
pubmed: 30467543
BMJ Open. 2021 Dec 2;11(12):e050785
pubmed: 34857567
BMJ. 2017 Aug 2;358:j3453
pubmed: 28768629
BMC Med. 2020 Apr 13;18(1):79
pubmed: 32279658
Front Rehabil Sci. 2022 Jul 22;3:877598
pubmed: 36189025
Front Med (Lausanne). 2022 Jan 20;8:811855
pubmed: 35127766
J R Soc Med. 2020 Jan;113(1):16-23
pubmed: 31922447
Age Ageing. 2023 Jan 8;52(1):
pubmed: 36729471
J Big Data. 2020;7(1):38
pubmed: 32834926
Res Involv Engagem. 2015 Jul 31;1:6
pubmed: 29062495
Health Res Policy Syst. 2019 Mar 28;17(1):33
pubmed: 30922339
Patterns (N Y). 2022 Jun 10;3(6):100506
pubmed: 35755870
Eur Urol Focus. 2021 Sep;7(5):947-950
pubmed: 34598912
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
Acta Anaesthesiol Scand. 2018 Aug;62(7):945-952
pubmed: 29512139
Digit Biomark. 2020 Sep 15;4(3):69-77
pubmed: 33083687
Res Involv Engagem. 2021 Aug 23;7(1):57
pubmed: 34425911
Res Involv Engagem. 2016 Apr 27;2:15
pubmed: 29062516
BMJ Open. 2022 May 2;12(5):e059400
pubmed: 35501096
Digit Biomark. 2020 Nov 26;4(Suppl 1):13-27
pubmed: 33442578

Auteurs

Alison Keogh (A)

Insight Centre Data Analytics, University College Dublin, Dublin4, Ireland.
School of Medicine, Trinity College Dublin, Dublin2, Ireland.

Ríona Mc Ardle (R)

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Mara Gabriela Diaconu (MG)

Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Nadir Ammour (N)

Clinical Science and Operations, Global Development, Sanofi Research & Development, Chilly-Mazarin, France.

Valdo Arnera (V)

Clario, Clario Holdings Inc, Geneva, Switzerland.

Federica Balzani (F)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Gavin Brittain (G)

Department of Clinical Neurology, Sheffield Teaching Hospitals National Health Service, Foundation Trust, Sheffield, United Kingdom.
Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, United Kingdom.

Ellen Buckley (E)

Department of Mechanical Engineering, University of Sheffield, Sheffield, United Kingdom.
Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.

Sara Buttery (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Alma Cantu (A)

School of Computer Science, Newcastle University, Newcastle, United Kingdom.

Solange Corriol-Rohou (S)

AstraZeneca Research and Development, Global Regulatory Excellence, Paris, France.

Laura Delgado-Ortiz (L)

Non-Communicable Diseases and Environment Programme, ISGlobal, Barcelona, Spain.
Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Centro de Investigación Biomedical en Red Epidemiologia y Salud Publica, Barcelona, Spain.

Jacques Duysens (J)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Tom Forman-Hardy (T)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Tova Gur-Arieh (T)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Dominique Hamerlijnck (D)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

John Linnell (J)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Letizia Leocani (L)

Department of Neurology, San Raffele University, Milan, Italy.

Tom McQuillan (T)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Isabel Neatrour (I)

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.

Ashley Polhemus (A)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Werner Remmele (W)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Isabel Saraiva (I)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Kirsty Scott (K)

Department of Mechanical Engineering, University of Sheffield, Sheffield, United Kingdom.
Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.

Norman Sutton (N)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Koen van den Brande (K)

Mobilise-D Patient and Public Advisory Group, Newcastle, United Kingdom.

Beatrix Vereijken (B)

Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Martin Wohlrab (M)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
University of Tuebingen, Tuebingen, Germany.

Lynn Rochester (L)

Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom.
Newcastle Upon Tyne Hospitals National Health Service Foundation Trust, Newcastle, United Kingdom.
See Acknowledgments, .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH